The Use of Heparinase Improves the Specificity of Crossreactivity Testing in Heparin-induced Thrombocytopenia

Thromb Haemost 1996; 76(06): 1121
DOI: 10.1055/s-0038-1650717

Letters to the Editor

Schattauer GmbH Stuttgart

Bernd Pötzsch

The Hemostasis Research Unit, Kerkhoff-Klinik, Max-Planck-Institut für physiologische und klinische Forschung, 61231 Bad Nauheim, Germany

,

Martin Keller

The Hemostasis Research Unit, Kerkhoff-Klinik, Max-Planck-Institut für physiologische und klinische Forschung, 61231 Bad Nauheim, Germany

,

Katharina Madlener

The Hemostasis Research Unit, Kerkhoff-Klinik, Max-Planck-Institut für physiologische und klinische Forschung, 61231 Bad Nauheim, Germany

,

Gert Müller-Berg-Haus

The Hemostasis Research Unit, Kerkhoff-Klinik, Max-Planck-Institut für physiologische und klinische Forschung, 61231 Bad Nauheim, Germany

References
1 Aster RH. Heparin-induced thrombocytopenia and thrombosis. N Engl J Med 1995; 332: 1374-6
2 Greinacher A, Potzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eck- hardt C. Heparin-associated thrombocytopenia: Isolation of the antibody and characterization of a multimolecular PF4-Heparin complex as the major antigen. Thromb Haemost 1994; 71: 247-51
3 Warkentin TE, Kelton JC. Heparin-induced thrombocytopenia. Prog Hemost Thromb 1991; 10: 1-34
4 Kikta MJ, Humphrey PW, Silver DS. Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome. Surgery 1993; 114: 705-10
5 Greinacher A, Michels I, Kiefel V, Mueller-Eckhardt C. A rapid and sensitive test for diagnosing heparin-induced thrombocytopenia. Thromb Haemost 1991; 66: 734-6